Search research articles
Contact Us
Filters
Showing results (81-90 of 85) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 85 results.
Head & Neck
|
October 28, 2024
Increased PD-1/PD-L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never-Smokers and Never-Drinkers
Mathias Fiedler, Alisa Off, Andreas Gärtner, et al.
Circulation
|
February 18, 2010
Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart
Jeremias Wohlschlaeger, Bodo Levkau, Gero Brockhoff, et al.
International Journal of Oncology
|
September 3, 2009
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition
Stefan Buchholz, Stephan Seitz, Andrew V Schally, et al.
Molecular Oncology
|
December 16, 2023
Subcellular localization of PD-L1 and cell-cycle-dependent expression of nuclear PD-L1 variants: implications for head and neck cancer cell functions and therapeutic efficacy
Daniela Schulz, Laura Feulner, Dominique Santos Rubenich, et al.
International Journal of Cancer
|
December 20, 2021
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease
Anja Kathrin Wege, Eva-Maria Rom-Jurek, Paul Jank, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 85) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 85 results.
Head & Neck
|
October 28, 2024
Increased PD-1/PD-L1 Immune Checkpoint Expression Is Associated With Oral Squamous Cell Carcinoma in Never-Smokers and Never-Drinkers
Mathias Fiedler, Alisa Off, Andreas Gärtner, et al.
Circulation
|
February 18, 2010
Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content in the failing human heart
Jeremias Wohlschlaeger, Bodo Levkau, Gero Brockhoff, et al.
International Journal of Oncology
|
September 3, 2009
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition
Stefan Buchholz, Stephan Seitz, Andrew V Schally, et al.
Molecular Oncology
|
December 16, 2023
Subcellular localization of PD-L1 and cell-cycle-dependent expression of nuclear PD-L1 variants: implications for head and neck cancer cell functions and therapeutic efficacy
Daniela Schulz, Laura Feulner, Dominique Santos Rubenich, et al.
International Journal of Cancer
|
December 20, 2021
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease
Anja Kathrin Wege, Eva-Maria Rom-Jurek, Paul Jank, et al.
Page
of 9